tiprankstipranks
Ligand Pharma (LGND)
NASDAQ:LGND
US Market

Ligand Pharma (LGND) Income Statement

Compare
802 Followers

Ligand Pharma Income Statement

Last quarter (Q4 2024), Ligand Pharma's total revenue was $42.81M, an increase of 52.35% from the same quarter last year. In Q4, Ligand Pharma's net income was $-31.09M. See Ligand Pharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 167.13M$ 131.31M$ 196.25M$ 277.13M$ 186.42M
Gross Profit
$ 156.06M$ 96.27M$ 143.42M$ 214.96M$ 156.00M
Operating Expenses
$ 178.66M$ 84.32M$ 140.38M$ 136.06M$ 147.27M
Depreciation and Amortization
$ 35.24M$ 37.41M$ 43.39M$ 41.34M$ 27.97M
EBITDA
$ 40.79M$ 101.73M$ 54.41M$ 133.16M$ 69.05M
Operating Income
$ -22.61M$ 11.94M$ -25.50M$ 78.89M$ 8.55M
Other Income/Expenses
$ 25.12M$ 51.72M$ 32.97M$ -31.65M$ -36.38M
Pretax Income
$ 2.52M$ 63.66M$ 36.01M$ 47.30M$ -10.54M
Net Income
$ -4.03M$ 52.15M$ -5.22M$ 57.14M$ -2.98M
Per Share Metrics
Basic EPS
$ -0.22$ 3.02$ -0.31$ 3.44$ -0.18
Diluted EPS
$ -0.22$ 2.94$ -0.31$ 3.31$ -0.18
Weighted Average Shares Outstanding
18.29M 17.30M 16.87M 16.63M 16.18M
Weighted Average Shares Outstanding (Diluted)
18.29M 17.76M 16.87M 17.25M 16.18M
Currency in USD

Ligand Pharma Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis